Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 September 2023: Clinical Research

Early Echocardiography and ECG Changes Following Radiotherapy in Patients with Stage II–III HER2-Positive Breast Cancer Treated with Anthracycline-Based Chemotherapy with or without Trastuzumab-Based Therapy

Radu Valeriu Toma 12ABCG , Zgura Anca 1E , Oana Gabriela Trifănescu 12A , Laurenţia Nicoleta Galeş 12D* , Antonia Ruxandra Folea 2CDEF , Loredana Stanca 3B , Liviu Bîlteanu 234ABCDEF* , Rodica M. Anghel 1A

DOI: 10.12659/MSM.941754

Med Sci Monit 2023; 29:e941754

Supplementary Table 14 The period (in days) from the start of therapy (CHT – chemotherapy, RT – radiotherapy, TT – targeted therapy) to the time of recording the worsening or the emergence of the diastolic dysfunction through delayed relaxation (DDDR), murmurs and valvular heart disease (MVHD), cardiomyopathies and left ventricular conditions (CLVC), great vessels diseases (GVD) and pericardial disease (PD).

DDDRMVHD
CHTTTRTCHTTTRT
Mean330.2339.0299.5288.2334.9270.0
SE Mean67.871.1108.958.868.591.8
Median221260252241293164
SD279.6256.4266.7242.4227.1243.0
Variance78201.765726.271144.358746.251562.359043.7
Range796725650808649651
Minimum61421321112
Maximum857767663810660663
Percentiles25105.0123.043.097.5137.0142.0
33135.6137.097.3122.4138.9155.4
50221.0260.0252.0241.0293.0164.0
67434.3447.2484.6377.5533.1319.5
75520.5621.5588.8404.5583.0564.0
Mean352.2213.3162.8292.0352.529131
SE Mean47.349.954.3138.8259.5
Median403163.5154183352.529131
SD142.0141.1108.7277.6367.0
Variance20159.419908.511810.377048.0134680.5
Range394360205606519
Minimum13042699893
Maximum524402274704612
Percentiles25214.0105.069.3119.093.0
33241.3105.069.7152.693.0
50403.0163.5154.0183.0352.5
67460.4342.3250.6366.0.
75481.5373.3265.0574.0.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750